Recommendations of the second update of the LONTS guidelines : Long-term opioid therapy for chronic noncancer pain

The second scheduled update of the German S3 guidelines on long-term opioid therapy for chronic noncancer pain (CNCP), the LONTS (AWMF registration number 145/003), was started in December 2018. The guidelines were developed by 28 scientific societies and 2 patient self-help organizations under the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Schmerz (Berlin, Germany) Germany), 2020-06, Vol.34 (3), p.204-244
Hauptverfasser: Häuser, Winfried, Bock, Frietjof, Hüppe, Michael, Nothacker, Monika, Norda, Heike, Radbruch, Lukas, Schiltenwolf, Marcus, Schuler, Matthias, Tölle, Thomas, Viniol, Annika, Petzke, Frank
Format: Artikel
Sprache:ger
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 244
container_issue 3
container_start_page 204
container_title Schmerz (Berlin, Germany)
container_volume 34
creator Häuser, Winfried
Bock, Frietjof
Hüppe, Michael
Nothacker, Monika
Norda, Heike
Radbruch, Lukas
Schiltenwolf, Marcus
Schuler, Matthias
Tölle, Thomas
Viniol, Annika
Petzke, Frank
description The second scheduled update of the German S3 guidelines on long-term opioid therapy for chronic noncancer pain (CNCP), the LONTS (AWMF registration number 145/003), was started in December 2018. The guidelines were developed by 28 scientific societies and 2 patient self-help organizations under the coordination of the German Pain Society. A systematic literature search in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and Scopus databases (up until December 2018) was performed. The systematic reviews with meta-analyses of randomized controlled trials with opioids for CNCP from the previous versions of the guideline were updated. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. The strength of the recommendations was established by formal multistep procedures in order to reach a consensus according to the Association of the Medical Scientific Societies in Germany (AWMF) regulations. The guidelines were reviewed by four external pain physicians. Public comments were possible for 4 weeks. Opioid-based analgesics are a drug-based treatment option for short-term (4-12 weeks), intermediate-term (13-25 weeks) and long-term (≥26 weeks) therapy of chronic osteoarthritis, diabetic polyneuropathy, postherpetic neuralgia and low back pain. Contraindications are primary headaches as well as functional somatic syndromes and mental disorders with the (cardinal) symptom pain. Based on a clinical consensus the guidelines list other medical conditions for which a therapy with opioids can be considered on an individual basis. Long-term therapy of CNCP with opioids is associated with relevant risks. A responsible administration of opioids requires consideration of possible indications and contraindications as well as regular assessment of efficacy and adverse effects. Opioids remain a treatment option for CNCP if nonpharmacological therapies are not effective and/or other drugs are not effective, are not tolerated or are contraindicated.
doi_str_mv 10.1007/s00482-020-00472-y
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2399845304</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2399845304</sourcerecordid><originalsourceid>FETCH-LOGICAL-c190t-49f41f394e63fa8c6d52f512e9c09ecd02cf85d0c4dad72dcbe43cf9eff9b4953</originalsourceid><addsrcrecordid>eNo1kEtLAzEYRYMgtlb_gAvJ0k00r3nEnYgvGCxoXQ9p8qWNzCRjMrPov7diu7qXw-EuLkJXjN4ySqu7TKmsOaGckn2rONmdoDmTghPOuJqh85y_KaWlKIozNBNcVFVdsjlKH2Bi30OwevQxZBwdHreA8x4Hi6dhz-EIm-X76hNvJm-h8wEyvsdNDBsyQupxHHz09s9LethhFxM22xSDNzjEYHQwkPCgfbhAp053GS4PuUBfz0-rx1fSLF_eHh8aYpiiI5HKSeaEklAKp2tT2oK7gnFQhiowlnLj6sJSI622FbdmDVIYp8A5tZaqEAt08787pPgzQR7b3mcDXacDxCm3XChVy0JQuVevD-q07sG2Q_K9Trv2-JP4BX58aqs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2399845304</pqid></control><display><type>article</type><title>Recommendations of the second update of the LONTS guidelines : Long-term opioid therapy for chronic noncancer pain</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Häuser, Winfried ; Bock, Frietjof ; Hüppe, Michael ; Nothacker, Monika ; Norda, Heike ; Radbruch, Lukas ; Schiltenwolf, Marcus ; Schuler, Matthias ; Tölle, Thomas ; Viniol, Annika ; Petzke, Frank</creator><creatorcontrib>Häuser, Winfried ; Bock, Frietjof ; Hüppe, Michael ; Nothacker, Monika ; Norda, Heike ; Radbruch, Lukas ; Schiltenwolf, Marcus ; Schuler, Matthias ; Tölle, Thomas ; Viniol, Annika ; Petzke, Frank ; Koautoren für die Konsensusgruppe der 2. Aktualisierung der S3-Leitlinie LONTS</creatorcontrib><description>The second scheduled update of the German S3 guidelines on long-term opioid therapy for chronic noncancer pain (CNCP), the LONTS (AWMF registration number 145/003), was started in December 2018. The guidelines were developed by 28 scientific societies and 2 patient self-help organizations under the coordination of the German Pain Society. A systematic literature search in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and Scopus databases (up until December 2018) was performed. The systematic reviews with meta-analyses of randomized controlled trials with opioids for CNCP from the previous versions of the guideline were updated. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. The strength of the recommendations was established by formal multistep procedures in order to reach a consensus according to the Association of the Medical Scientific Societies in Germany (AWMF) regulations. The guidelines were reviewed by four external pain physicians. Public comments were possible for 4 weeks. Opioid-based analgesics are a drug-based treatment option for short-term (4-12 weeks), intermediate-term (13-25 weeks) and long-term (≥26 weeks) therapy of chronic osteoarthritis, diabetic polyneuropathy, postherpetic neuralgia and low back pain. Contraindications are primary headaches as well as functional somatic syndromes and mental disorders with the (cardinal) symptom pain. Based on a clinical consensus the guidelines list other medical conditions for which a therapy with opioids can be considered on an individual basis. Long-term therapy of CNCP with opioids is associated with relevant risks. A responsible administration of opioids requires consideration of possible indications and contraindications as well as regular assessment of efficacy and adverse effects. Opioids remain a treatment option for CNCP if nonpharmacological therapies are not effective and/or other drugs are not effective, are not tolerated or are contraindicated.</description><identifier>EISSN: 1432-2129</identifier><identifier>DOI: 10.1007/s00482-020-00472-y</identifier><identifier>PMID: 32377861</identifier><language>ger</language><publisher>Germany</publisher><subject>Analgesics, Opioid - therapeutic use ; Chronic Pain - drug therapy ; Evidence-Based Medicine ; Germany ; Humans ; Societies, Medical</subject><ispartof>Schmerz (Berlin, Germany), 2020-06, Vol.34 (3), p.204-244</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c190t-49f41f394e63fa8c6d52f512e9c09ecd02cf85d0c4dad72dcbe43cf9eff9b4953</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32377861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Häuser, Winfried</creatorcontrib><creatorcontrib>Bock, Frietjof</creatorcontrib><creatorcontrib>Hüppe, Michael</creatorcontrib><creatorcontrib>Nothacker, Monika</creatorcontrib><creatorcontrib>Norda, Heike</creatorcontrib><creatorcontrib>Radbruch, Lukas</creatorcontrib><creatorcontrib>Schiltenwolf, Marcus</creatorcontrib><creatorcontrib>Schuler, Matthias</creatorcontrib><creatorcontrib>Tölle, Thomas</creatorcontrib><creatorcontrib>Viniol, Annika</creatorcontrib><creatorcontrib>Petzke, Frank</creatorcontrib><creatorcontrib>Koautoren für die Konsensusgruppe der 2. Aktualisierung der S3-Leitlinie LONTS</creatorcontrib><title>Recommendations of the second update of the LONTS guidelines : Long-term opioid therapy for chronic noncancer pain</title><title>Schmerz (Berlin, Germany)</title><addtitle>Schmerz</addtitle><description>The second scheduled update of the German S3 guidelines on long-term opioid therapy for chronic noncancer pain (CNCP), the LONTS (AWMF registration number 145/003), was started in December 2018. The guidelines were developed by 28 scientific societies and 2 patient self-help organizations under the coordination of the German Pain Society. A systematic literature search in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and Scopus databases (up until December 2018) was performed. The systematic reviews with meta-analyses of randomized controlled trials with opioids for CNCP from the previous versions of the guideline were updated. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. The strength of the recommendations was established by formal multistep procedures in order to reach a consensus according to the Association of the Medical Scientific Societies in Germany (AWMF) regulations. The guidelines were reviewed by four external pain physicians. Public comments were possible for 4 weeks. Opioid-based analgesics are a drug-based treatment option for short-term (4-12 weeks), intermediate-term (13-25 weeks) and long-term (≥26 weeks) therapy of chronic osteoarthritis, diabetic polyneuropathy, postherpetic neuralgia and low back pain. Contraindications are primary headaches as well as functional somatic syndromes and mental disorders with the (cardinal) symptom pain. Based on a clinical consensus the guidelines list other medical conditions for which a therapy with opioids can be considered on an individual basis. Long-term therapy of CNCP with opioids is associated with relevant risks. A responsible administration of opioids requires consideration of possible indications and contraindications as well as regular assessment of efficacy and adverse effects. Opioids remain a treatment option for CNCP if nonpharmacological therapies are not effective and/or other drugs are not effective, are not tolerated or are contraindicated.</description><subject>Analgesics, Opioid - therapeutic use</subject><subject>Chronic Pain - drug therapy</subject><subject>Evidence-Based Medicine</subject><subject>Germany</subject><subject>Humans</subject><subject>Societies, Medical</subject><issn>1432-2129</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kEtLAzEYRYMgtlb_gAvJ0k00r3nEnYgvGCxoXQ9p8qWNzCRjMrPov7diu7qXw-EuLkJXjN4ySqu7TKmsOaGckn2rONmdoDmTghPOuJqh85y_KaWlKIozNBNcVFVdsjlKH2Bi30OwevQxZBwdHreA8x4Hi6dhz-EIm-X76hNvJm-h8wEyvsdNDBsyQupxHHz09s9LethhFxM22xSDNzjEYHQwkPCgfbhAp053GS4PuUBfz0-rx1fSLF_eHh8aYpiiI5HKSeaEklAKp2tT2oK7gnFQhiowlnLj6sJSI622FbdmDVIYp8A5tZaqEAt08787pPgzQR7b3mcDXacDxCm3XChVy0JQuVevD-q07sG2Q_K9Trv2-JP4BX58aqs</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Häuser, Winfried</creator><creator>Bock, Frietjof</creator><creator>Hüppe, Michael</creator><creator>Nothacker, Monika</creator><creator>Norda, Heike</creator><creator>Radbruch, Lukas</creator><creator>Schiltenwolf, Marcus</creator><creator>Schuler, Matthias</creator><creator>Tölle, Thomas</creator><creator>Viniol, Annika</creator><creator>Petzke, Frank</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202006</creationdate><title>Recommendations of the second update of the LONTS guidelines : Long-term opioid therapy for chronic noncancer pain</title><author>Häuser, Winfried ; Bock, Frietjof ; Hüppe, Michael ; Nothacker, Monika ; Norda, Heike ; Radbruch, Lukas ; Schiltenwolf, Marcus ; Schuler, Matthias ; Tölle, Thomas ; Viniol, Annika ; Petzke, Frank</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c190t-49f41f394e63fa8c6d52f512e9c09ecd02cf85d0c4dad72dcbe43cf9eff9b4953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2020</creationdate><topic>Analgesics, Opioid - therapeutic use</topic><topic>Chronic Pain - drug therapy</topic><topic>Evidence-Based Medicine</topic><topic>Germany</topic><topic>Humans</topic><topic>Societies, Medical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Häuser, Winfried</creatorcontrib><creatorcontrib>Bock, Frietjof</creatorcontrib><creatorcontrib>Hüppe, Michael</creatorcontrib><creatorcontrib>Nothacker, Monika</creatorcontrib><creatorcontrib>Norda, Heike</creatorcontrib><creatorcontrib>Radbruch, Lukas</creatorcontrib><creatorcontrib>Schiltenwolf, Marcus</creatorcontrib><creatorcontrib>Schuler, Matthias</creatorcontrib><creatorcontrib>Tölle, Thomas</creatorcontrib><creatorcontrib>Viniol, Annika</creatorcontrib><creatorcontrib>Petzke, Frank</creatorcontrib><creatorcontrib>Koautoren für die Konsensusgruppe der 2. Aktualisierung der S3-Leitlinie LONTS</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Schmerz (Berlin, Germany)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Häuser, Winfried</au><au>Bock, Frietjof</au><au>Hüppe, Michael</au><au>Nothacker, Monika</au><au>Norda, Heike</au><au>Radbruch, Lukas</au><au>Schiltenwolf, Marcus</au><au>Schuler, Matthias</au><au>Tölle, Thomas</au><au>Viniol, Annika</au><au>Petzke, Frank</au><aucorp>Koautoren für die Konsensusgruppe der 2. Aktualisierung der S3-Leitlinie LONTS</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recommendations of the second update of the LONTS guidelines : Long-term opioid therapy for chronic noncancer pain</atitle><jtitle>Schmerz (Berlin, Germany)</jtitle><addtitle>Schmerz</addtitle><date>2020-06</date><risdate>2020</risdate><volume>34</volume><issue>3</issue><spage>204</spage><epage>244</epage><pages>204-244</pages><eissn>1432-2129</eissn><abstract>The second scheduled update of the German S3 guidelines on long-term opioid therapy for chronic noncancer pain (CNCP), the LONTS (AWMF registration number 145/003), was started in December 2018. The guidelines were developed by 28 scientific societies and 2 patient self-help organizations under the coordination of the German Pain Society. A systematic literature search in the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and Scopus databases (up until December 2018) was performed. The systematic reviews with meta-analyses of randomized controlled trials with opioids for CNCP from the previous versions of the guideline were updated. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine. The strength of the recommendations was established by formal multistep procedures in order to reach a consensus according to the Association of the Medical Scientific Societies in Germany (AWMF) regulations. The guidelines were reviewed by four external pain physicians. Public comments were possible for 4 weeks. Opioid-based analgesics are a drug-based treatment option for short-term (4-12 weeks), intermediate-term (13-25 weeks) and long-term (≥26 weeks) therapy of chronic osteoarthritis, diabetic polyneuropathy, postherpetic neuralgia and low back pain. Contraindications are primary headaches as well as functional somatic syndromes and mental disorders with the (cardinal) symptom pain. Based on a clinical consensus the guidelines list other medical conditions for which a therapy with opioids can be considered on an individual basis. Long-term therapy of CNCP with opioids is associated with relevant risks. A responsible administration of opioids requires consideration of possible indications and contraindications as well as regular assessment of efficacy and adverse effects. Opioids remain a treatment option for CNCP if nonpharmacological therapies are not effective and/or other drugs are not effective, are not tolerated or are contraindicated.</abstract><cop>Germany</cop><pmid>32377861</pmid><doi>10.1007/s00482-020-00472-y</doi><tpages>41</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1432-2129
ispartof Schmerz (Berlin, Germany), 2020-06, Vol.34 (3), p.204-244
issn 1432-2129
language ger
recordid cdi_proquest_miscellaneous_2399845304
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Analgesics, Opioid - therapeutic use
Chronic Pain - drug therapy
Evidence-Based Medicine
Germany
Humans
Societies, Medical
title Recommendations of the second update of the LONTS guidelines : Long-term opioid therapy for chronic noncancer pain
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T07%3A46%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recommendations%20of%20the%20second%20update%20of%20the%20LONTS%20guidelines%20:%20Long-term%20opioid%20therapy%20for%20chronic%20noncancer%20pain&rft.jtitle=Schmerz%20(Berlin,%20Germany)&rft.au=H%C3%A4user,%20Winfried&rft.aucorp=Koautoren%20f%C3%BCr%20die%20Konsensusgruppe%20der%202.%20Aktualisierung%20der%20S3-Leitlinie%20LONTS&rft.date=2020-06&rft.volume=34&rft.issue=3&rft.spage=204&rft.epage=244&rft.pages=204-244&rft.eissn=1432-2129&rft_id=info:doi/10.1007/s00482-020-00472-y&rft_dat=%3Cproquest_pubme%3E2399845304%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2399845304&rft_id=info:pmid/32377861&rfr_iscdi=true